Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta‐Piccoli, et al.
Clinical Reviews in Allergy & Immunology (2017) Vol. 54, Iss. 1, pp. 147-176
Closed Access | Times Cited: 302

Showing 1-25 of 302 citing articles:

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
Akito Hasegawa, Riichiro Abe
F1000Research (2020) Vol. 9, pp. 612-612
Open Access | Times Cited: 144
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types
Rolf Teschke
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Case Report: Diagnostic Challenges of Pancreatic Cancer in a Patient With Stevens–Johnson Syndrome
Po‐Chien Wu, Yi‐Teng Hung, Jennifer Wu
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 3
Open Access | Times Cited: 1
<p>NSAID-induced reactions: classification, prevalence, impact, and management strategies</p>
Natalia Blanca‐López, Víctor Soriano, Elena García‐Martín, et al.
Journal of Asthma and Allergy (2019) Vol. Volume 12, pp. 217-233
Open Access | Times Cited: 64
Current Perspectives on Severe Drug Eruption
Jingzhan Zhang, Zixian Lei, Xu Chen, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 282-298
Open Access | Times Cited: 42
A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Hua‐Ching Chang, Tsung-Jen Wang, Ming‐Hsiu Lin, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 32
Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020
Liqin Wang, Sheril Varghese, Fatima Bassir, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 31
Drug-Induced Anaphylaxis: National Database Analysis
О. И. Бутранова, S. К. Zyryanov, Anastasia Gorbacheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 90-90
Open Access | Times Cited: 7
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy
Min Lin, Ting Gong, Shi‐Fan Ruan, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2337-2351
Open Access | Times Cited: 7
Tumor necrosis factor-α inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series
Yu-Ting Peng, Jianxia Xiong, Bin Wei, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 1
Open Access | Times Cited: 6
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis
Xue-Yan Chen, Bing-Xi Yan, Xiao‐Yong Man
Therapeutic Advances in Respiratory Disease (2020) Vol. 14
Open Access | Times Cited: 41
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
Paul V. Viscuse, Mario L. Marques‐Piubelli, Meghan Heberton, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis)
Cindy E. Owen, Jordan Jones
Medical Clinics of North America (2021) Vol. 105, Iss. 4, pp. 577-597
Closed Access | Times Cited: 39
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
Emanuele Micaglio, Emanuela H. Locati, Michelle M. Monasky, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Lin Cheng
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Drug Hypersensitivity Reactions
R. Gentry Wilkerson
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 3, pp. 473-489
Closed Access | Times Cited: 16
Regenerative Therapy for Corneal Scarring Disorders
Christine Chandran, Mithun Santra, Elizabeth Rubin, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 649-649
Open Access | Times Cited: 6
To Debride or Not to Debride: A Review of Wound Management for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Christina D. Enescu, A. Elder, Hany Deirawan, et al.
Cureus (2024)
Open Access | Times Cited: 5
Antibiotic Hypersensitivity Mechanisms
Jenana H. Maker, Cassandra M. Stroup, Vanthida Huang, et al.
Pharmacy (2019) Vol. 7, Iss. 3, pp. 122-122
Open Access | Times Cited: 40
Drug Hypersensitivity Reactions
R. Gentry Wilkerson
Emergency Medicine Clinics of North America (2021) Vol. 40, Iss. 1, pp. 39-55
Closed Access | Times Cited: 30
Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies
Yanping Li, Ruoqiu Fu, Tingting Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
Gábor Tóth, Andrea Lukács, F. Schirra, et al.
Ophthalmology and Therapy (2023) Vol. 12, Iss. 4, pp. 1795-1811
Open Access | Times Cited: 13
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis
Yuki Saito, Riichiro Abe
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 4, pp. 271-278
Closed Access | Times Cited: 11
The Multifold Etiologies of Limbal Stem Cell Deficiency: A Comprehensive Review on the Etiologies and Additional Treatment Options for Limbal Stem Cell Deficiency
Majid Moshirfar, Maliha Masud, Devon H. Harvey, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4418-4418
Open Access | Times Cited: 11
Adalimumab combination with corticosteroid therapy for Stevens–Johnson syndrome/toxic epidermal necrolysis
Jia Liu, Mengyun Zhou, Taoye Li, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top